Silveira, Brysa Mariana Dias; https://orcid.org/0000-0002-6369-6768; http://lattes.cnpq.br/9901380509695840
Resumo:
Chronic leg ulcers (CLU) are common microvascular complications in patients with
sickle cell anemia. CLUs are recalcitrant and the absence of treatment can lead to
lower limb amputation. Adipose tissue stromal cells (ASC) represent an alternative for
the treatment of CLUs, due to their ability to secrete soluble mediators involved in
tissue repair. Thus, we evaluated the effects of the ASC secretome in vitro model of
umbilical cord endothelial cells (HUVECs) and in vivo model with transgenic Nestin-
GFP+/NG2-DsRed+ mice and sickle Towness mice. Our work found that the secret of
ASC preconditioned in normoxia (condition with 20% oxygen) and hypoxia (condition
with 5% oxygen) presented in its composition markers of tissue regeneration (eg:
VEGF, MCP1, IL-8 and angiogenin). In vitro analysis demonstrated that both
conditioned media (CMs) exerted anti-apoptotic and angiogenic action on HUVECs,
with better performance of cells treated with CM in normoxia. Our in vivo model using
C57BL/6 transgenic mice revealed radiation from the healing process of wounds
treated with MCs. Considering that our therapeutic product performed better under
conditions of normoxia, we analyzed the therapeutic potential of MC normoxia in
wound healing model with sickle cell mice. In this work, we sought to evaluate the proangiogenic
and immunomodulatory effect in skins treated with CM using
immunohistochemistry, immunofluorescence and RT-PCR techniques. Our results
revealed that CM administration was able to stimulate the healing process by reducing
local inflammation, increasing the number of fibroblasts and increasing collagen
production. Just as we identified reduced expression of inflammatory transcripts,
evidencing the therapeutic effect of MC on immunomodulation.